MedTrace Logo

Progressive Muscle Relaxation (PMR) in Stress Management Among Physiotherapy Students

NCT06028360 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-09-28

No results posted yet for this study

Summary

The objective of this clinical trial is to observe the effect of Virtual Reality (VR) and Progressive muscle relaxation (PMR) in stressed individuals.

Procedure:

Students will be invited verbally and procedure will be explained to them. 20 students will be recruited randomly into control and experimental group. Stress will be predicted using multiple questionnaires. Pss is given before and after the intervention. The students in control group will be given 10 mins session of PMR for 3 consecutive days and in intervention group will be given 10 mins session of PMR followed by 8 mins session of VR for 3 consecutive days in which specific landscapes i.e mountains, forests, nightskies and beaches.

Conditions

  • Stress

Interventions

OTHER

Progressive Muscle Relaxation

Intervention will be applied for 15-20 minutes 3 consecutive days a week for 1 week

DEVICE

Virtual Reality Therapy

Therapy through VR will be given for 8 minutes 3 times a week on consecutively for 1 week

Sponsors & Collaborators

  • Shalamar Institute of Health Sciences

    lead OTHER

Principal Investigators

  • Reema Khanam, DPT · Shalamar Medical and Dental College

  • Laiba Khan, DPT · Shalamar Medical and Dental College

  • Maha Sohail, DPT · Shalamar Medical and Dental College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2023-11-10
Completion
2023-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06028360 on ClinicalTrials.gov